Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy.
A patient with angioimmunoblastic lymphadenopathy (AILD) is presented. Manifestations of the disease appeared after short-term treatment with oxprenolol hydrochloride. Following treatment with prednisone, the patient remained in remission for 25 months. The disease relapsed following reuse of oxprenolol hydrochloride. Severe pancytopenia due to bone marrow involvement by AILD and myelofibrosis led to a fatal outcome. The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed. In addition, the possible relationship between AILD and oxprenolol hydrochloride is considered.
D000787:Angina Pectoris / Q000188:drug therapy; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy; D010096:Oxprenolol / Q000009:adverse effects; D010198:Pancytopenia / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000150:complications* / Q000473:pathology
D010096:Oxprenolol; D011241:Prednisone